Phase 2 Candidiasis Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis
National Institute of Allergy and Infectious Diseases (NIAID)10 enrolled1 locationNCT07202598
Recruiting
Phase 2
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
Alopecia AreataAutoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
National Institute of Allergy and Infectious Diseases (NIAID)70 enrolled1 locationNCT05398809
Recruiting
Phase 2Phase 3
Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis
Candidal Vulvovaginitis (ICD-10 Code: B37.3)Vulvovaginal Candidiasis (VVC)
AVVA Pharmaceuticals Ltd.264 enrolled7 locationsNCT06835361
Recruiting
Phase 2
A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis
Patients With Candidemia and/or Invasive Candidiasis
Fujian Shengdi Pharmaceutical Co., Ltd.40 enrolled1 locationNCT06194201
Recruiting
Phase 2Phase 3
Postbiotic as Adjunct Treatment for Vaginal Candidiasis
Vaginal Candidiasis
Min-Tze LIONG118 enrolled2 locationsNCT06474247
Recruiting
Phase 2
Oral safety and efficacy of eucalypt sap resin in the management of recurrent vulvovaginal candidiasis
recurrent vulvovaginal candidiasis
Integria Healthcare (Australia) Pty Ltd.24 enrolled1 locationACTRN12624000204549